Treatment Updates for mCRC

 

ASCO 2022 Conference Coverage
J

Lecture Summary - ASCO 2022 Adjuvant Chemotherapy Guided by ctDNA Analysis in Stage II Colon Cancer: The Randomized DYNAMIC Trial

By ASCO 2022 Conference Coverage FEATURING Jeanne Tie
By ASCO 2022 Conference Coverage FEATURING Jeanne Tie
12 views
July 7, 2022
0 Comments
Login to view comments. Click here to Login
Treatment Updates for mCRC
15:07
UCSF School of Medicine

Impact of Primary Tumor Location on OS and PFS in Patients with mCRC…

Feat. A. Venook
16:00
ecancer

Tumor Agnostic Treatments in GI Cancers: Liquid Bipsy, Biomarkers

Feat. N. Normanno, K. Schmitz
11:42
Penn Medicine Abramson Cancer Center

Penn Medicine Updates on the Role of Systemic Therapy in CRC Liver M…

Feat. T. Karasic
30:15
Houston Methodist Hospital

Role of Systemic Therapy in Colorectal Cancer

Feat. M. O. Khalil
27:45
CECOG Academy

Adjuvant Treatment of Colon Cancer: Duration of Treatment and Patien…

Feat. G. Prager
41:57
2022 Community Oncology Conference

The Colorectal Cancer Epidemic: Root Causes & Remedies

Feat. R. Goldberg
09:32
Michael Hummel

BRAF Testing in Metastatic Colorectal Carcinoma and Novel, Chemother…

11:34
ASCO 2022 Conference Coverage

ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as Initial Treatment …

Feat. C. Cremolini
34
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as …

Feat. C. Cremolini
10:29
ASCO 2022 Conference Coverage

ASCO 2022 Using cfDNA to Identify Guideline-Relevant Biomarkers for …

Feat. P. Kasi
18:02
Nebraska Oncology Society

ASCO 2022 Updates on RAS/BRAF/KRAS/NRAS Wild-Type mCRC: Summary of R…

Feat. G. Kim
09:14
Nebraska Oncology Society

ASCO 2022 Updates on Colon Cancer Treatment

Feat. G. Kim
02:15
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Adjuvant Chemotherapy Guided by ctDNA An…

Feat. J. Tie
07:56
ASCO 2022 Conference Coverage

ASCO 2022 on RAS Co-Mutation and Early Onset Disease Represent an Ag…

Feat. B. Johnson
13:16
ESMO 2022 Conference Coverage

ESMO 2022 on the NICHE-2 Study: Neoadjuvant Immune Checkpoint Inhibi…

Feat. M. Chalabi
29:47
Fortunato Ciardiello

Treatment Sequencing in mCRC

13:02
Yale Cancer Center

Personalized Treatment for Patients Living With mCRC

Feat. M. Cecchini